Results
|
161.
|
|
|
162.
|
|
|
163.
|
|
|
164.
|
|
|
165.
|
|
|
166.
|
|
|
167.
|
|
|
168.
|
|
|
169.
|
|
|
170.
|
|
|
171.
|
|
|
172.
|
|
|
173.
|
|
|
174.
|
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. [electronic resource] by
- Tutt, A L
- French, R R
- Illidge, T M
- Honeychurch, J
- McBride, H M
- Penfold, C A
- Fearon, D T
- Parkhouse, R M
- Klaus, G G
- Glennie, M J
Producer: 19981006
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 161
Availability: No items available.
|
|
175.
|
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. [electronic resource] by
- Weisman, H F
- Bartow, T
- Leppo, M K
- Marsh, H C
- Carson, G R
- Concino, M F
- Boyle, M P
- Roux, K H
- Weisfeldt, M L
- Fearon, D T
Producer: 19900823
In:
Science (New York, N.Y.) vol. 249
Availability: No items available.
|
|
176.
|
Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21). [electronic resource] by
- Fearon, D T
- Klickstein, L B
- Wong, W W
- Wilson, J G
- Moore, F D
- Weis, J J
- Weis, J H
- Jack, R M
- Carter, R H
- Ahearn, J A
Producer: 19891226
In:
Progress in clinical and biological research vol. 297
Availability: No items available.
|